Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
Problem Tech Solves
Tech Brief
There are more people with diagnosable and subclinical mental health syndromes than there are clinicians to treat them. This was only amplified by increased demand for mental health care during the COVID-19 pandemic. People have never felt ever more disconnected, and this is a recipe for problematic day-to-day mental health maintenance. Woebot delivers mental health principles that were previously only available in the clinic to people via the devices they use every day. 56% of user messages on Woebot are sent on weekends or outside of traditional working hours (9 a.m.-5 p.m.) and the longest conversations occur between the hours of 2 a.m.-5 a.m. Those moments of need are the most clinically potent to engage in a step-by-step therapeutic technique and offer significant potential for symptom reduction. Today, mental health care delivery is organized around systems administration, therapists and the assumption that a human is needed to form a bond, rather than relationships. This makes quality of care variable and out of touch with users’ needs, with tools that lack responsiveness, personalization, and the ability to adapt to real-world events, patient symptoms and preferences. Woebot was developed based on hundreds of hours of clinical training, as well as deep research and development that enables the app to meet people where they are –eliciting rich, contextual data points and offering targeted micro-interventions. Woebot Health’s team of clinically trained writers, physicians, cutting-edge engineers and experts in machine learning and AI together combine their disciplines to build an impactful mental health tool.
Tech Differentiators
Woebot Health has created the first proprietary relational agent for mental health. Developed by licensed clinical psychologists, Woebot can develop a bond with users and deliver deeply engaging and effective therapeutic solutions for depression and anxiety. The bond Woebot is able to form with its users has been shown to be on-par with the bond created between human therapists and patients. Evidence of Woebot’s ability to form this bond with users was demonstrated in a study published in JMIR Formative Research. Among more than 36,000 users, the team discovered Woebot’s bond is: •Comparable to traditional human-delivered services across treatment modalities and significantly higher than computerized cognitive behavioral therapy programs •Established in just 3-5 days—far faster than the bond scores in comparison studies that were all measured between 2-6 weeks •Non-diminishing over time as shown by the nearly identical bond scores from a group of people talking to Woebot at 8 weeks In the same way that relationships must be nurtured between people, so must the connection between virtual mental health services and their users. The Woebot Health team regularly evaluates performance and retrains models to ensure its technology adapts to the evolving world. This process requires collaboration between clinicians and technologists to understand how individuals interact with digital solutions, identify where interventions are needed and generate thoughtful and clinically effective responses.With a proactive approach grounded in the authenticity of human bonds, Woebot Health is building dynamic digital experiences that enable users to shape their own mental health journey.
Validation
Woebot Health has a long track record of conducting scientific research. The company has conducted 7 RCTs, and is the single most mentioned DTx company in peer-reviewed scientific literature with nearly a dozen peer-reviewed publications to date. In addition to the JMIR Formative Research bond study mentioned above, Woebot Health’s initial controlled study conducted at Stanford University showed that using Woebot led to significant reductions in anxiety and depression among 70 study participants aged 18-28 years old in just two weeks. A previous study in substance use disorder (SUD), published in JMIR, showed that 101 people with SUD who used Woebot while sheltering in place experienced a 30% decrease in substance use occasions, a 50% decrease in cravings, increased confidence to resist urges (36%) and a decrease in symptoms of depression (21%) and anxiety (23%).
